Jing Wang
Nebraska Medical Center(US)University of Nebraska Medical Center(US)
Publications by Year
Research Areas
TGF-β signaling in diseases, Pancreatic and Hepatic Oncology Research, PI3K/AKT/mTOR signaling in cancer, Genetic factors in colorectal cancer, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Reduced Expression of Transforming Growth Factor β Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells(1996)121 cited
- → Transforming Growth Factor β Induces Apoptosis through Repressing the Phosphoinositide 3-Kinase/AKT/Survivin Pathway in Colon Cancer Cells(2008)99 cited
- → TGF-Beta Suppresses VEGFA-Mediated Angiogenesis in Colon Cancer Metastasis(2013)87 cited
- → Design of Noncovalent Inhibitors of Human Cathepsin L. From the 96-Residue Proregion to Optimized Tripeptides(2002)75 cited
- → Phosphatase PRL-3 Is a Direct Regulatory Target of TGFβ in Colon Cancer Metastasis(2010)56 cited
- → Characterization of CDK(5) inhibitor, 20-223 (aka CP668863) for colorectal cancer therapy(2017)52 cited
- → Smad4-dependent TGF-β Signaling Suppresses RON Receptor Tyrosine Kinase-dependent Motility and Invasion of Pancreatic Cancer Cells(2008)51 cited
- → TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cells(2017)38 cited
- → A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer(2016)32 cited
- → Autocrine and Exogenous Transforming Growth Factor β Control Cell Cycle Inhibition through Pathways with Different Sensitivity(2004)28 cited